SCHEMBL29700392

SCHEMBL29700392

O=C(CC1CCCS(=O)(=O)C1)NC1CC2(C1)CC(c1nc3cc(Cl)ccc3s1)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ LMNA P02545 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ CNR2 P34972 2/20 0.37
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ GLA P06280 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 2/20 0.33
▸ HCRTR1 O43613 1/20 0.33
▸ CXCR6 O00574 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26185597 1.00 NPC1 (0.40) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL29700405 0.91 NPC1 (0.41) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL26185598 0.91 NPC1 (0.41) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL24478841 0.90 NPC1 (0.44) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL26185570 0.89 NPC1 (0.41) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL29700429 0.89 NPC1 (0.41) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL29700425 0.82 NPC1 (0.43) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL26185602 0.82 NPC1 (0.43) NPC1RAB9ALMNAALDH1A1CNR2
SCHEMBL30505271 0.82 PTGES (0.39) ALDH1A1POLBKDM4EGLAKMT2A
SCHEMBL26225717 0.82 PTGES (0.39) ALDH1A1POLBKDM4EGLAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251615-B1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2025-10-15 — — EP claimed
EP-4251615-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 — — EP claimed
WO-2022112188-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 — — WO claimed
EP-4251615-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 — — EP disclosed
WO-2022112188-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 — — WO disclosed
Send feedback